All Immunology articles – Page 2
-
NewsLong-term HIV control: Could this combination therapy be the key?
A new study shows it may be possible to control HIV without long-term antiviral treatment — an advance that points the way toward a possible cure for a disease that affects 40 million people around the world.
-
NewsMeasles deaths down 88% since 2000, but cases surge
Global immunization efforts have led to an 88% drop in measles deaths between 2000 and 2024, according to a new report from the World Health Organization (WHO). Nearly 59 million lives have been saved by the measles vaccine since 2000.
-
News Lack of dietary iron may impair immune cells’ ability to fight influenza
New research suggests that a lack of dietary iron can negatively affect the ability of immune cells to respond to viral infection in the lungs. In mice with dietary iron deficiency and influenza, immune cells struggled to produce a key signal needed to fight viruses and did not regain this ability.
-
NewsFractional-dose vaccines can save millions during shortages
New research shows that using smaller, fractional doses of vaccines can significantly reduce infections during epidemics, especially when vaccine supply, delivery, or administration capacity is limited.
-
NewsCuring hepatitis C can rebalance immunity in Indonesians living with HIV
A new study provides the first longitudinal immunological data on HIV/HCV-coinfected individuals in Southeast Asia, underscoring the importance of early hepatitis C treatment to prevent long-term immune and liver complications.
-
NewsExpanding seasonal immunization access could minimize off-season RSV epidemics
Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and concluded that year-round immunizations would minimize risks of large seasonal outbreaks.
-
NewsExperimental mRNA therapy shows potential to combat antibiotic-resistant infections
Researchers have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. In preclinical studies, the therapy slowed bacterial growth, strengthened immune cell activity, and reduced lung tissue damage in models of multidrug-resistant pneumonia.
-
NewsGut microbiome connects obesity to cancer, impacting public health
A new review highlights growing scientific evidence that imbalances in gut bacteria can influence metabolism, trigger inflammation, and increase cancer risk. These insights offer new possibilities for disease prevention, early detection, and personalized health care.
-
NewsNew study identifies key mechanism driving HIV-associated immune suppression
Using humanized mouse models and blood samples from people living with HIV, resarchers found that reducing overactive plasmacytoid dendritic cells helped restore antiviral T cell function and shrink the viral reservoir.
-
NewsSnakebites: COVID vaccine tech could limit venom damage
The same technology used in COVID-19 vaccines could help prevent muscle damage from snakebites, according to scientists who say it could be even more useful for other conditions where toxins cause harm gradually, such as blocking harmful toxins produced by bacteria during infections.
-
NewsNew vaccine against a deadly virus acts fast and protects for over a year
A research team has developed a vaccine made from a non-infectious version of the Crimean-Congo hemorrhagic fever virus that protects quickly and provides long-lasting immunity.
-
NewsNatural, non-engineered bacterium selectively targets colorectal cancer
Scientists have demonstrated that the marine bacterium Photobacterium angustum exhibits potent antitumor effects against colorectal cancer. The natural bacterium requires no genetic modification yet selectively accumulates in tumor tissues with minimal impact on healthy organs.
-
NewsScientists uncover how COVID-19 variants outsmart the immune system
Researchers have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations weaken that attachment.
-
NewsNew research confirms HPV vaccination prevents cervical cancer
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.
-
NewsRebalancing lung repair with immune damage is key to surviving severe influenza
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies with immune modulation can restore damaged tissues and lung function, even after severe infection has taken hold.
-
NewsToxic gut bacteria may drive ulcerative colitis by killing protective immune cells
A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new treatment strategies.
-
NewsGSK and Fleming Initiative scientists unite to target AMR with advanced AI
GSK and the Fleming Initiative have announced six major new research programmes, called ‘Grand Challenges’ which harness some of the best scientific expertise and the latest technologies, including advanced AI, to find new ways to slow the progress of antimicrobial resistance (AMR).
-
NewsGut bacterium impairs liver cancer treatment, inducing immunotherapy resistance
Researchers discovered that transplanting the gut bacterium Phocaeicola vulgatus into mouse models of liver cancer induced immunotherapy resistance. The finding is consistent with clinical observations in patients, showing that patients with low levels of P. vulgatus responded better to treatment.
-
NewsScripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.
-
NewsPig disease vaccine effectiveness linked to T cell response
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the production of antibodies. The work is an important step in identifying specific targets for vaccines on a rapidly mutating virus.